Bodor JN, Patel JD, Wakelee HA, Levy BP, et al. Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked. Clin Lung Cancer 2023 May 11:S1525-7304(23)00097.
PMID: 37451930